T1	Participants 573 662	Mexican patients with type 2 diabetes who received pioglitazone or glimepiride for 1 year
T2	Participants 1551 1698	Two hundred forty-four patients (125 women, 119 men; all but 1 Hispanic) were randomized to receive pioglitazone (n = 121) or glimepiride (n = 123)
